DISCLAIMER — Not financial advice. Educational content only, not an offer or solicitation to buy or sell any security. Biotech and small/mid-cap stocks are highly speculative and volatile and can result in a partial or total loss of capital. Do your own research and consult a licensed advisor where appropriate. / Contenuti a solo scopo informativo e didattico, non costituiscono consulenza finanziaria né offerta o sollecitazione al pubblico risparmio ai sensi delle normative CONSOB e SEC. Le azioni biotech e le small/mid cap sono strumenti altamente speculativi e volatili e possono comportare la perdita parziale o totale del capitale investito. Si raccomanda di effettuare sempre le proprie ricerche e, se necessario, di rivolgersi a un consulente abilitato.
Read / Leggi Disclaimer

Category CTM

Castellum Inc

Castellum ($CTM) — 2025 repaired the story

Castellum came out of 2025 looking cleaner, less leveraged and more credible than it did a year earlier. Revenue grew, operating losses narrowed sharply, cash improved, debt was almost fully gone by year-end and then fully eliminated shortly after. The central question now is no longer whether CTM can tell a better story, but whether it can turn backlog, contract wins and pipeline into durable margins and more repeatable cash generation in 2026.

Castellum Inc ($CTM) – FY 2025 Results & 2026 Execution

On March 4, 2026, Castellum Inc. announced its unaudited FY 2025 financial results, and the numbers reveal a company that has fundamentally shifted trajectory. After years of acquisition-driven roll-up activity, balance sheet stress, and constant capital raises, CTM is now reporting organic revenue growth, positive adjusted EBITDA, and—perhaps most significantly—has completely eliminated all outstanding debt. This is not a dramatic overnight turnaround; rather, it is the culmination of methodical execution: progressive debt paydown, operational efficiency improvements, successful Navy contract wins, and a disciplined capital allocation strategy that prioritizes sustainability over growth-at-any-cost.

Castellum Inc ($CTM) Now Debt Free

From heavily leveraged roll-up to cash-rich, debt-free federal contractor: what changes after the last note payoff, how the Navy “Big 3” contracts reshape visibility, and what still can go wrong for shareholders.

CTM Castellum Inc

Castellum starts 2026 with exactly what you want to see in a micro-cap defense name: more work, bigger visibility inside the U.S. missile-defense and Navy ecosystem, and a tape that already gave traders a clean spike-and-fade on the first new contract of the year.

CTM Castellum Inc

In early December 2025 Castellum’s CEO Glen Ives released a year-end shareholder letter summarizing a step-change year: record Q3 revenue, the company’s first GAAP net profit, significant debt reduction, and a contract backlog that more than doubled year-on-year. The letter also highlights a 103.3 million dollar NAVAIR Special Missions contract (via GTMR), a 66.2 million dollar NAWCAD Lakehurst prime contract for the SSI subsidiary, and fresh awards under the Missile Defense Agency’s SHIELD IDIQ program.